Articles tagged "Liver transplantation"

2020 American Transplant Congress
Higher Probability of Living Donor Liver Transplantation is Associated with DSAs Having a Higher Median Meld at Transplant
D. Haakinson¹, S. Noreen², D. Stewart², R. Batra¹, G. Gan¹, Y. Deng¹, S. Kulkarni¹
¹Yale, New Haven, CT, ²UNOS, Richmond, VA
*Purpose: Recent studies show that outcomes of living donor liver transplantation (LDLT) are superior compared to those receiving deceased donor grafts. Access to deceased donor…
2020 American Transplant Congress
Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplantation
K. J. Dery¹, K. Nakamura², K. Kadono¹, H. Hirao¹, S. Kageyama¹, T. Ito¹, H. Kojima¹, F. Kaldas¹, R. W. Busuttil¹, J. W. Kupiec-Weglinski¹
¹Department of Surgery, Division of Liver and Pancreas Transplantation, UCLA, Los Angeles, CA, ²Surgery, Nishi-Kobe Medical Center, Hyogo, Japan
*Purpose: Ischemia-reperfusion injury (IRI) represents a risk factor in liver transplantation (LT). We have shown that overexpression of heme oxygenase 1 (HO-1) mitigates hepatic IRI…
2020 American Transplant Congress
Management of Hepatic Artery Stenosis Post Liver Transplant
S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta
Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ
*Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…
2020 American Transplant Congress
Duration of Pre-Transplant Abstinence Does Not Predict Severe Relapses of Alcohol Abuse in High-Risk Alcoholic Liver Transplant Recipients
W. H. Kitchens
Emory Transplant Center, Atlanta, GA
*Purpose: The traditional requirement of >6 months pre-transplant sobriety for liver transplant recipients has been challenged by emerging literature, but risk factors for post-transplant recidivism…
2020 American Transplant Congress
Association between Alcoholic Liver Disease and Alcohol Tax
S. Melo¹, A. Ermekbaeva², J. Buggs³, E. Rogers³, A. Kumar⁴, N. Kemmer⁵
¹School of Medicine, Indiana University, Indianapolis, IN, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Morsani College of Medicine, University of South Florida, Tampa, FL, ⁵Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: The incidence of Alcoholic Liver Disease (ALD) has increased, causing ALD to become a primary indication for liver transplantation in the United States. We…
2020 American Transplant Congress
The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation
M. Chen¹, X. Lin², Z. Chen¹, M. Han¹, W. Ju¹, X. He¹
¹Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Division of General Surgery, The East Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Liver transplantation (LT) is considered as the only curable treatment for patients with end stage liver diseases. Post-operative complications include early allograft dysfunction (EAD),…
2020 American Transplant Congress
Bedside Ultrasound to Assess for Sarcopenia in Cirrhotic Patients Undergoing Inpatient Liver Transplant Evaluation
M. Aguilar¹, E. A. Rodriguez¹, A. Andrekus², S. Buckner-Petty², N. Dahiya², E. J. Carey²
¹GI/Hepatology, Mayo-Arizona, Scottsdale, AZ, ²Mayo-Arizona, Scottsdale, AZ
*Purpose: Sarcopenia is routinely assessed during outpatient evaluation for liver transplant (LT) candidacy in cirrhotic patients as it is associated with poor clinical outcomes. Skeletal…
2020 American Transplant Congress
Microbiota Modulates Ischemia-Reperfusion Injury in Mouse Liver Transplantation
S. Kageyama¹, H. Kojima¹, K. Kadono¹, H. Hirao¹, K. J. Dery¹, K. Nakamura², T. Dong³, J. Jacobs³, R. W. Busuttil¹, J. W. Kupiec-Weglinski¹
¹Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA, ²Surgery, Nishi Kobe Medical Center, Kobe, Japan, ³The Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) is a major risk factor in orthotopic liver transplantation (OLT). As host microbiota may associate with health or disease, antibiotics (Abx)…
2020 American Transplant Congress
The Addition of Splenectomy to Simultaneous Liver Kidney Transplantation Improves Class II DSA Clearance in Sensitized Patients
V. Fleetwood, D. Aufhauser, C. Papageorge, K. Janek, L. Hidalgo, B. Welch, R. Redfield, J. Mezrich
Department of Transplantation, University of Wisconsin, Madison, WI
*Purpose: The liver allograft clears class I donor specific antibody (DSA) more effectively than class II DSA. Persistent class II DSA in simultaneous liver kidney…
2020 American Transplant Congress
Living Donor Liver Transplantation Demonstrated Superiority to Deceased Donor Transplantation after Adult-To-Adult Liver Transplantation in Cumulative Single-Center Retrospective Cohort Study of 19 Years
T. Goto, T. Reichman, G. Sapisochin, I. McGilvray, M. Selzner, A. Ghanekar, M. Cattral, N. Selzner
Multi-Organ Transplant Program, Toronto General Hospital, Institute of Medical Science, University of Toronto, Toronto, ON, Canada
*Purpose: Living donor liver transplantation (LDLT) is an alternative way to deceased donor liver transplantation (DDLT). LDLT and DDLT showed similar short-term outcomes of recipient…